1016106

Adamas Pharmaceuticals, Inc. — FEI 3007281742

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 26, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Emeryville, CA (United States)

Additional Details

Sponsor, Contract Research Organization